A Comparative Study on the Efficacy of Heparin Ointment and Hirudoid Cream on Treatment of Thrombophlebitis Resulted From Intravenous Catheter Insertion and Multidrug Infusion
Authors/Creators
- 1. Associate Professor, Dept. of Anaesthesiology, VSSIMSAR, Burla, Sambalpur, Odisha, India
- 2. Associate Professor, Dept. of General Surgery, VSSIMSAR, Burla, Sambalpur, Odisha, India
- 3. Assistant Professor, Dept. of Anaesthesiology, VSSIMSAR, Burla, Sambalpur, Odisha, India
- 4. Professor, Dept. of Anaesthesiology, VSSIMSAR, Burla, Sambalpur, Odisha, India
- 5. Senior Resident, Dept. of Anaesthesiology, VSSIMSAR, Burla, Sambalpur, Odisha, India
- 6. Junior Resident, Dept. of Anaesthesiology, VSSIMSAR, Burla, Sambalpur, Odisha, India
Description
Background and Aim: Intravenous cannulation is the most common invasive procedure in hospitals. Phlebitis is the most frequent complication of intravenous therapy. We aimed to compare the effect of heparin ointment and hirudoid cream on treating intravenous catheter-induced superficial thrombophlebitis and multidrug infusions. Methodology: This prospective randomized study was conducted on 160 patients of both genders, above 18 years of age, who had superficial thrombophlebitis and had given informed consent, were randomly assigned into two groups: Group-A (Heparin ointment) and Group-B (Hirudoid cream). Heparin ointment or Hirudoid cream was applied thrice daily over the surface of the phlebitis lesion. Phlebitis grading was assessed for each patient from the first day of treatment to the seventh day of treatment or till the complete resolution of symptoms. The effectiveness of the treatment was assessed using the Visual Infusion Phlebitis Scale (VIP). Result: In the Heparin ointment group the mean VIP score after treatment was significantly lower (p=<0.001) than hirudoid cream group from day 3 to day 5. The quality of treatment was excellent in 77.5% of patients in the heparin group than 58.75% of patients in the hirudoid group (p=0.009). The mean duration of treatment days was significantly less p=<0.001 in the heparin group (5.79 days) compared to the hirudoid group (6.30 days). Conclusion: Heparin ointment administered topically thrice daily is better in comparison to Hirudoid cream application for treatment of superficial thrombophlebitis due to intravenous catheter insertion.
Abstract (English)
Background and Aim: Intravenous cannulation is the most common invasive procedure in hospitals. Phlebitis is the most frequent complication of intravenous therapy. We aimed to compare the effect of heparin ointment and hirudoid cream on treating intravenous catheter-induced superficial thrombophlebitis and multidrug infusions. Methodology: This prospective randomized study was conducted on 160 patients of both genders, above 18 years of age, who had superficial thrombophlebitis and had given informed consent, were randomly assigned into two groups: Group-A (Heparin ointment) and Group-B (Hirudoid cream). Heparin ointment or Hirudoid cream was applied thrice daily over the surface of the phlebitis lesion. Phlebitis grading was assessed for each patient from the first day of treatment to the seventh day of treatment or till the complete resolution of symptoms. The effectiveness of the treatment was assessed using the Visual Infusion Phlebitis Scale (VIP). Result: In the Heparin ointment group the mean VIP score after treatment was significantly lower (p=<0.001) than hirudoid cream group from day 3 to day 5. The quality of treatment was excellent in 77.5% of patients in the heparin group than 58.75% of patients in the hirudoid group (p=0.009). The mean duration of treatment days was significantly less p=<0.001 in the heparin group (5.79 days) compared to the hirudoid group (6.30 days). Conclusion: Heparin ointment administered topically thrice daily is better in comparison to Hirudoid cream application for treatment of superficial thrombophlebitis due to intravenous catheter insertion.
Files
IJPCR,Vol16,Issue8,Article218.pdf
Files
(405.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:55b09492edf03d2a783efe7fd612d6c6
|
405.3 kB | Preview Download |
Additional details
Dates
- Accepted
-
2024-07-26
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/16/IJPCR,Vol16,Issue8,Article218.pdf
- Development Status
- Active
References
- 1. Sharifi J, Ghavami F, Nowrouzi Z et al. Oral versus intravenous rehydration therapy in severe gastroenteritis. Archives of Disease in Childhood, 1985, 60, 856-860. doi: 10.1136/adc.60.9.856 2. Oliveira A.S and Parreira P.M. Nursing interventions and peripheral venous catheter related phlebitis. Systemic literature review. Referencia: Scientific Journal of the Health Science Research Unit: Nursing, 2010, 3(2):137-147. 3. Dougherty L. Peripheral cannulation. Nursing Standard (Royal College of Nursing (Great Britain): 2008; 22(52) 49–56. DOI:10.7748/ ns2008.09.22.52.49.c66504. Feldstein, A. Detect phlebitis and infiltration before they affect your patient. Nursing 1986; 16: 44-47. 5. Webster J, Osborne S, Rickard CM, Marsh N. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database of Systematic Reviews. 2019 Jan 23; 1(1):CD007798 CD007798. DOI: 10.1002/14651858.CD007798.pub5 PMID: 30671926 PMCID: PMC6353131 6. Dos Reis PE, Silveira RC, Vasques CI, de Carvalho EC. Pharmacological interventions to treat phlebitis: systematic review. Journal of infusion Nursing; 2009 Mar-Apr; 32(2):74-79. DOI: 10.1097/NAN.0b013e318198d497 7. Katakkar SB. Use of Heparin as a Topical Antithrombotic and Anti-inflammatory Agent, JNCI: Journal of the National Cancer Institute; 1993; 85 (22): 1865-1866 https://doi.org/10. 1093/jnci/85.22.1865 8. De Moerloose P, Gavillet O, Salomon D, et al. Heparin-related activity in peripheral venous blood after percutaneous application of various glycosaminoglycan containing creams. Blood Coagulation and Fibrinolysis: 1992 Dec; 3 (6): 827-828 DOI: 10.1097/00001721-199212000- 00040 9. Composition of Thrombophob Ointment. https://www.medplusmart.com/product/thromb ophob-20gm-gel_thro0001 10. Composition of Hirudoid cream. https://www. medicines.org.uk/emc/product/1341/smpc#gref 11. De Angelis CP, De Nicola P, Bianco G, et al. Clinical evaluation of the effectiveness and tolerance of heparin as a topical therapy in vascular diseases [in Italian]. Antolog Med Italiana 1985; 5: 524-527 12. Gallant, Paulette BSN, RNC, et al. Evaluation of a Visual Infusion Phlebitis Scale for Determining Appropriate Discontinuation of Peripheral Intravenous Catheters, Journal of Infusion Nursing: November 2006; 29(6): 338-345 DOI: 10.1097/00129804-200611000-00004 PMID: 1712268 13. Basanta Thapa, Laxmi Rajbanshi, Govinda Prasad Dhungana, Babita Devi Dahal, "Contributing Factors of Peripheral Intravenous Catheter Related Phlebitis among Patients at a Teaching Hospital, Chitwan", International Journal of Science and Research(IJSR), Volume 8 Issue 4, April 2019, 1019 - 1024 https://www.ijsr.net/get_abstract.php?paper_id =ART20196992, 14. Salma U, Sarker M, Zafrin N, Ahamed K. Frequency of Peripheral Intravenous Catheter Related Phlebitis and Related Risk Factors: A Prospective Study. Journal of Medicine 2019; 20(1):29-33. https://doi.org/10.3329/jom.v20i1.38818 15. Gazitua R, Wilson K, Bistrian BR, Blackburn GL. Factors Determining Peripheral Vein Tolerance to Amino Acid Infusions. Archives of Surgery. 1979; 114(8):897–900. doi: 10.1001/ archsurg.1979.013703 20029005 16. Cicolini, G., Bonghi, A.P., Di Labio, L., & Di Mascio, R. Position of peripheral venous cannulae and the incidence of thrombophlebitis: an observational study. Journal of Advanced Nursing. 2009; 65 (6), 1268-1273 https://doi. org/10.1111/j.1365-2648.2009.04980.x 17. Panadero A, Iohom G, Taj J, et al. A dedicated intravenous cannula for postoperative use effect on incidence and severity of phlebitis. Anaesthesia. 2002 Sep; 57(9): 921-925. doi: 10.1046/j.1365-2044. 2002. 02786.x 18. Vilardell M, Sabat D, Arnaiz JA, et al. Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter. A double-blind, randomized, placebocontrolled trial. Eur J Clin Pharmacol. 1999 Feb; 54(12):917-921. doi: 10.1007/s0022800 50575 19. D'Amico N, Greco N, Ruotolo G, Colonna CV. A clinical contribution to pharmacology in venous pathology and its complications: effects of heparin in the form of a gel [in Italian]. Minerva Cardioangiol. 1987 Apr; 35(4):195- 203 PMID: 3601108. 20. Inga C, Pignocchino P, Casini A, et al. Clinical evaluation of a gel with a high heparin content [in Italian]. Minerva Angiolog 1985; 10(3): 247-249.